Navigation Links
Treatment Of Brain Aneurysms By A New Non-Surgical Approach

Aneurysm refers to a sac formed by localized dilation of the wall of an artery, a vein or the heart. A brain aneurysm arises as a result of weakness in the arterial wall of the brain. Rupture of the aneurysm can result in // stroke or death.

A new approach combining the use of intracranial stents and coil embolization to strengthen the artery has been proposed as a treatment for the condition. It also saves the trouble of a complicated surgery that would involve opening of the skull.

Coil embolization is a procedure in which tiny coils are used to close off the aneurysm. A catheter inserted into the femoral artery (a blood vessel in the upper leg) is used to deliver the coils to the aneurysm in the blood vessels of the brain. The procedure is not without limitations.

Coil embolization is currently used to treat approximately 30 percent of cerebral aneurysms. The procedure is less invasive and requires significantly less recovery time than open surgery for aneurysm repair. Additional benefits include minimal blood loss and the option for local anesthesia.

If the aneurysm was more than 4mm, the "wide neck" of the aneurysm prevented the coil from staying in place on its own and the aneurysm was very likely to return.

The introduction of flexible intracranial stents has provided an answer to retaining stents within the aneurysm, thereby preventing recurrence. This provides minimally invasive option for repairing of cerebral aneurysms. Furthermore, the procedure has been found to be very effective in 90% of the cases, resulting in complete closure of the aneurysm without compromising the parent vessel at least six months after the procedure.

"Our results are encouraging because they demonstrate that devices like the intracranial stent will continue to not only improve our ability to treat challenging wide-necked aneurysms without opening the skull but also to have a significant impact on re-treatment rate s" said Lopes, one of the experts in the field.

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: